- Home
- EVAX vs ZONE Comparison
EVAX vs ZONE Comparison
Compare EVAX & ZONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- ZONE
- Stock Information
- Founded
- EVAX 2008
- ZONE 2022
- Country
- EVAX Denmark
- ZONE United States
- Employees
- EVAX N/A
- ZONE N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- ZONE
- Sector
- EVAX Health Care
- ZONE
- Exchange
- EVAX Nasdaq
- ZONE NYSE
- Market Cap
- EVAX 8.7M
- ZONE 10.3M
- IPO Year
- EVAX 2021
- ZONE 2024
- Fundamental
- Price
- EVAX $2.49
- ZONE $1.12
- Analyst Decision
- EVAX Strong Buy
- ZONE
- Analyst Count
- EVAX 3
- ZONE 0
- Target Price
- EVAX $33.33
- ZONE N/A
- AVG Volume (30 Days)
- EVAX 6.9M
- ZONE 382.7K
- Earning Date
- EVAX 03-26-2025
- ZONE 02-14-2025
- Dividend Yield
- EVAX N/A
- ZONE N/A
- EPS Growth
- EVAX N/A
- ZONE N/A
- EPS
- EVAX N/A
- ZONE N/A
- Revenue
- EVAX $3,295,000.00
- ZONE $1,643,051.00
- Revenue This Year
- EVAX $9,039.73
- ZONE N/A
- Revenue Next Year
- EVAX $1.47
- ZONE N/A
- P/E Ratio
- EVAX N/A
- ZONE N/A
- Revenue Growth
- EVAX N/A
- ZONE N/A
- 52 Week Low
- EVAX $2.22
- ZONE $0.87
- 52 Week High
- EVAX $22.50
- ZONE $4.24
- Technical
- Relative Strength Index (RSI)
- EVAX 39.85
- ZONE N/A
- Support Level
- EVAX $2.30
- ZONE N/A
- Resistance Level
- EVAX $2.80
- ZONE N/A
- Average True Range (ATR)
- EVAX 0.51
- ZONE 0.00
- MACD
- EVAX 0.03
- ZONE 0.00
- Stochastic Oscillator
- EVAX 6.97
- ZONE 0.00
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About ZONE CLEANCORE SOLUTIONS INC
CleanCore Solutions Inc engages in the development and manufacturing of cleaning products that produce pure aqueous ozone for professional, industrial, or home use. The firm has a patented nanobubble technology using aqueous ozone that is effective in cleaning, sanitizing, and deodorizing surfaces and high-touch areas. The company offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. Its products are used in many types of environments including retail establishments, distribution centers, factories, warehouses, restaurants, schools and universities, airports, healthcare, food service, and commercial buildings such as offices, malls, and stores.